vialroom

#retatrutide 2024-08-27

Tuesday21 messages7 participantstimes are UTC
Highlights from this day
  • VialBot — Recon calculator: 30mg in 2ml = 2mg/ml. 14:00
  • quiet.hours — blood pressure stayed flat for me while heart rate moved, which i didnt expect 14:28
  • u100_pat — is the GI worse than tirzepatide or about the same 14:32
  • quiet.hours — slightly off topic but anyone compared their Medutest purity across two different QSC lots 14:33
  • apnoea_down_two — coming back to this i log resting heart rate every morning because of this and its the one number i actually watch 15:41
U1

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

A1

did the phase 2 result actually come in higher than the tirzepatide numbers

PS

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

QH

i said 7 months ago that my heart rate had settled and it has stayed settled since

QH

blood pressure stayed flat for me while heart rate moved, which i didnt expect

4
U1

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

is the GI worse than tirzepatide or about the same

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
QH

slightly off topic but anyone compared their Medutest purity across two different QSC lots

TA

for the archive triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history

[edited]
AD

coming back to this i log resting heart rate every morning because of this and its the one number i actually watch

sat at 1 for 2 months rather than climbing and it kept working, so i never went up, i think

triple agonist yeah

18